ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1252 • 2017 ACR/ARHP Annual Meeting

    Real-World Oral Methotrexate Adherence Measured Electronically in Patients with Established Rheumatoid Arthritis

    Kaleb Michaud1,2, Rebecca Schumacher2, Bernard Vrijens3, Eric Tousset3, Gorana Dasic4, Connie Chen4, Ekta Agarwal4 and Maria Suarez-Almazor5, 1University of Nebraska Medical Center, Omaha, NE, 2National Data Bank for Rheumatic Diseases, Wichita, KS, 3WestRock Healthcare, Visé, Belgium, 4Pfizer Inc, New York, NY, 5Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX

    Background/Purpose: While weekly methotrexate (MTX) remains the gold standard treatment for patients with RA, studies suggest that MTX adherence may be sub-optimal and could be…
  • Abstract Number: 1253 • 2017 ACR/ARHP Annual Meeting

    Patient Reported Outcomes Explain the Lack of Agreement between Physician and Patient Perceived Remission in Early Rheumatoid Arthritis

    Samina A. Turk1,2, Linda A. Rasch3, Willem F. Lems4,5, Lilian van Tuyl3, Dirkjan van Schaardenburg4,6 and Marieke M. Ter Wee5,7, 1Rheumatology, Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 2Rheumatology, Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 3Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 4Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 5Rheumatology, Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 6Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 7Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) patients increasingly reach a state of absence of disease activity, or remission. However, the proportion of patients classified as in remission…
  • Abstract Number: 1254 • 2017 ACR/ARHP Annual Meeting

    Eliciting the Research Priorities of Parents and Children with Juvenile Myositis

    Colleen K. Correll1, Mitali Dave2, Anne Paul3, Vincent Del Gaizo4 and Esi Morgan5, 1Pediatrics, University of Minnesota, Minneapolis, MN, 2Cure JM Foundation, Encintas, CA, 3Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Parent Partner, Whitehouse Station, NJ, 5Cincinnati Children's Hospital, Cincinnati, OH

    Background/Purpose: The Patient-Centered Outcomes Research Institute (PCORI) aims to improve the quality and relevance of research by conducting research that is of highest priority to…
  • Abstract Number: 1255 • 2017 ACR/ARHP Annual Meeting

    Using PROs to Guide Patient-Centered Conversations and Care in Inflammatory Arthritis: The Clinician Perspective

    Susan J. Bartlett1, Katherine Clegg Smith2, Elaine de Leon2, Michelle Jones3, Anna Kristina Gutierrez4, Allie Butanis5 and Clifton O. Bingham III6, 1Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 3Johns Hopkins University School of Medicine, Baltimore, MD, 4Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 5Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, 6Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Although patient-reported outcomes (PROs) are routinely collected for research and quality purposes, they have not been routinely incorporated into the routine care of patients.…
  • Abstract Number: 1256 • 2017 ACR/ARHP Annual Meeting

    Uptake of Influenza and Pneumococcal Vaccination in Inflammatory Arthritis

    Kieran Murray1 and Douglas J. Veale2, 1Rheumatology, Rheumatology Specialist Registrar, Dublin 4, Ireland, 2Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland

    Background/Purpose: Inflammatory arthritides such as RA and PsA increase infection risk. The Centre for Disease Control and Prevention (CDC) recommends vaccination against i. influenza for…
  • Abstract Number: 1257 • 2017 ACR/ARHP Annual Meeting

    A Scoping Review of Contextual Factors of Patient Decision Aids in Osteoarthritis

    Alexa Meara1, Karine Toupin-April2, Bev Shea3, Liana Fraenkel4, Jennifer Barton5, Peter Brooks6, Maarten de Wit7 and Peter Tugwell8, 1Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, 3University of Ottawa, Ottawa, ON, Canada, 4Yale University, New Haven, CT, 5Oregon Health and Science University, Portland, OR, 6The University of Queensland, Sidney, Australia, 7EULAR standing committee of PARE, Zurich, Switzerland, 8Center For Global Health, Institute of Population Hlth, Ottawa, ON, Canada

    Background/Purpose: Patient decision aids (PDAs) have been developed to help patients make informed health care decisions that are consistent with their values and preferences. Patients…
  • Abstract Number: 1258 • 2017 ACR/ARHP Annual Meeting

    Divided By a Common Language: Challenges in Physician-Patient Communication Limit Patient Understanding and Support in Systemic Sclerosis with Interstitial Lung Disease (SSc-ILD)

    Christopher Denton1, Bee Laird2, Lizette Moros3 and José Luis Luna Flores4, 1Department of Rheumatology, University College London, Royal Free Hospital, London, United Kingdom, 2Reframe Research, East Sussex, United Kingdom, 3Boehringer-Ingelheim, Ingelheim, Germany, 4Boehringer Ingelheim, Ingelheim, Germany

    Background/Purpose: Systemic sclerosis is a potentially life-threatening, clinically diverse, and rare condition. The prognosis and course of disease is difficult to predict and treatment is…
  • Abstract Number: 1259 • 2017 ACR/ARHP Annual Meeting

    Perspectives of Young People with Juvenile Idiopathic Arthritis, Their Caregivers, and Health Care Providers on Transition to Adult Care: Informing Development of a Transition Toolkit

    Nadia Luca1, Evelyn Rozenblyum2, April Elliott3, Lynn R. Spiegel4, Nicole Johnson5, Sara Ahola Kohut6, Yvonne Brandelli3, Carolyn Johns7, Stephanie Luca8, Dianne P. Mosher9, Gordon Soon10, Karine Toupin-April11, Gabriela Uifalusi3 and Jennifer N. Stinson12, 1Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, 2Royal University Hospital, Saskatoon, SK, Canada, 3Alberta Children's Hospital, Calgary, AB, Canada, 4Rheumatology/Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada, 5Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada, 6Hospital for Sick Children, Toronto, ON, Canada, 7Alberta Health Services, Calgary, AB, Canada, 8The Hospital for Sick Children, Toronto, ON, Canada, 9Med, University of Calgary, Calgary, AB, Canada, 10Pediatric Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, 11Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, 12Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Transition from pediatric to adult care is an important process for adolescents and young adults with Juvenile Idiopathic Arthritis (JIA). A seamless transition is…
  • Abstract Number: 1260 • 2017 ACR/ARHP Annual Meeting

    Lupus Diagnosis: Process and Patient Experience

    Rossi Daly, Roushanac Partovi and Patricia Davidson, Lupus Foundation of America, Washington, DC

    Background/Purpose: Delays in lupus diagnosis and misdiagnosis are sources of concern, as uncontrolled disease activity and early damage can increase mortality risk.1 The purpose of…
  • Abstract Number: 1261 • 2017 ACR/ARHP Annual Meeting

    The Effects of Disease Burden, Helplessness, and Pain on Depressive Symptoms in Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Sera Ramadan1, Perry M. Nicassio2, George Karpouzas3 and Sarah Ormseth4, 1Internal Medicine, Dignity Health St. Mary Medical Center, Long Beach, CA, 2Cousins Center for PNI, UCLA, LA, CA, 3Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 4Rheumatology, Harbor-UCLA Medical Center, Torrance, CA

    Background/Purpose: This research tested an integrated framework examining patient global assessment of disease activity (PtGA), maladaptive illness beliefs and pain as determinants of mood disturbance…
  • Abstract Number: 1262 • 2017 ACR/ARHP Annual Meeting

    Stability of Two Short Medication Adherence Questionnaires over Time for Follow-up in Patients with Rheumatoid Arthritis

    Raquel Sweezie1, Charles H. Goldsmith2, Imy Chiu3, Anna Gutlin3, Sharron Sandhu4 and Mary J. Bell5, 1Division of Rheumatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, 2Simon Fraser University, Vancouver, BC, Canada, 3Rheumatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, 4Medicine, University of Toronto, Toronto, ON, Canada, 5University of Toronto, Toronto, ON, Canada

    Background/Purpose: Adherence to disease modifying anti-rheumatic drug (DMARD) therapy is suboptimal in patients with rheumatoid arthritis (RA). Efficient, low-cost measures are required for better monitoring…
  • Abstract Number: 1263 • 2017 ACR/ARHP Annual Meeting

    Relevance and Utility of Patient Reported Outcomes Measurement Information System (PROMIS®) Instruments in SLE: A Qualitative Study

    Shanthini Kasturi1, Madeline Epsten2, Adena Batterman3, Roberta Horton3, Juliette Kleinman3, Jillian Rose3, Jackie Szymonifka2, Laura Robbins4 and Lisa A. Mandl1, 1Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Social Work Programs, Hospital for Special Surgery, New York, NY, 4Education & Academic Affairs, Hospital for Special Surgery, New York, NY

    Background/Purpose: The measurement of patient reported outcomes is a priority for patient-centered high value care. This is particularly true in chronic systemic diseases such as…
  • Abstract Number: 1264 • 2017 ACR/ARHP Annual Meeting

    Responsiveness of Patient Reported Outcomes Measurement Information System (PROMIS®) Computerized Adaptive Tests (CATs) in Systemic Lupus Erythematosus (SLE)

    Shanthini Kasturi1, Jackie Szymonifka2, Jessica R. Berman3, Kyriakos A. Kirou1, Alana B. Levine1, Lisa R. Sammaritano1 and Lisa A. Mandl1, 1Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY

    Background/Purpose: PROMIS CATs are precise measures of quality of life with construct validity in SLE. The longitudinal responsiveness (sensitivity to change) of PROMIS CATs in…
  • Abstract Number: 1265 • 2017 ACR/ARHP Annual Meeting

    Impaired Cardiac Function in Juvenile Mixed Connective Tissue Disease Compared with Controls

    Birgit Nomeland Witczak1, Siri Opsahl Hetlevik2, Zoltan Barth1,3, Thomas Schwartz4,5, Berit Flatø2,6, Vibke Lilleby2,6 and Ivar Sjaastad1,6,7, 1Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 2Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, Oslo, Norway, 3Department of Pathophysiology and Gerontology, Medical School, University of Pècs, Pècs, Hungary, Pècs, Hungary, 4Oslo University Hospital and University of Oslo, Institute for Experimental Medical Research, Oslo, Norway, 5Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 6Institute for Clinical Medicine, University of Oslo, Oslo, Norway, Oslo, Norway, 7Department of Cardiology, Oslo University Hospital, Oslo, Norway, Oslo, Norway

    Background/Purpose: Juvenile MCTD (JMCTD) is a heterogenic autoimmune disease, with SLE-, SSc- and PM/DM and RA like manifestations. Cardiac involvement is known in juvenile SLE,…
  • Abstract Number: 1266 • 2017 ACR/ARHP Annual Meeting

    Geographic Variation in Use of Echocardiography at Diagnosis and Detection of Acute Cardiac Disease in Youth with Systemic Lupus Erythematosus

    Joyce C. Chang1, Andrea M. Knight2, Laura M. Mercer-Rosa3, Rui Xiao4 and Pamela F. Weiss5, 1Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2Division of Rheumatology, Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, 3Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, 4Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 5Division of Rheumatology, Center for Pediatric Clincial Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Child-onset systemic lupus erythematosus (SLE) is a chronic autoimmune condition with a high risk of organ damage. There are no guidelines on the use…
  • « Previous Page
  • 1
  • …
  • 1287
  • 1288
  • 1289
  • 1290
  • 1291
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology